Benutzer: Gast  Login
Titel:

[New therapy concepts for castration-resistant prostate cancer: between hormone manipulation, targeted therapy and chemotherapy].

Dokumenttyp:
English Abstract; Journal Article
Autor(en):
Kübler, H; Miller, K
Abstract:
Within the last 2 years the therapeutic landscape of castration-resistant prostate cancer (CRPC) has dramatically changed. While chemotherapy with docetaxel has only shown a survival benefit in CRPC patients in the last 10 years, in the meantime 4 approved drugs are available for this indication and approval for immunotherapy with sipuleucel-T is expected. Docetaxel still plays a significant role in the treatment of CRPC but is also a cesura in the therapeutic sequence. For asymptomatic or minim...     »
Zeitschriftentitel:
Urologe A
Jahr:
2013
Band / Volume:
52
Heft / Issue:
11
Seitenangaben Beitrag:
1517-8, 1520-1, 1524-6 pa
Sprache:
de
Volltext / DOI:
doi:10.1007/s00120-013-3247-9
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/24166056
Print-ISSN:
0340-2592
TUM Einrichtung:
Urologische Klinik und Poliklinik
 BibTeX